Chinese medtech startup SiBionics has raised nearly 500 million yuan ($71.7 million) in a Series D round of financing to expand its development of AI-based medical devices for chronic disease management.
Shenzhen-based SiBionics secured the new financing from lead investors Shanghai Biomedical Industrial Equity Investment Fund and Guangdong Chinese Medicine and Mass Health Fund, the startup announced on Wednesday.
